Stock AZN ASTRAZENECA PLC
Add to a list
To use this feature you must be a member
Log inSign up

Ratings AstraZeneca PLC Nasdaq Stockholm

Equities

AZN

GB0009895292

Market Closed - Nasdaq Stockholm
Other stock markets
 12:00:00 2024-07-12 pm EDT 		5-day change 1st Jan Change
1,676 SEK +2.38% Intraday chart for AstraZeneca PLC +3.65% +23.83%
Jul. 12 Instil Bio Shares Surge Following Rental Agreement with AstraZeneca DJ
Jul. 12 Sector Update: Health Care Stocks Mixed Premarket Friday MT

Strengths

  • Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
  • The company returns high margins, thereby supporting business profitability.
  • Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • Over the past four months, analysts' average price target has been revised upwards significantly.

Weaknesses

  • The company benefits from high valuations in earnings multiples.
  • The company's "enterprise value to sales" ratio is among the highest in the world.
  • The company appears highly valued given the size of its balance sheet.
  • The valuation of the company is particularly high given the cash flows generated by its activity.
  • Over the past twelve months, analysts' opinions have been revised negatively.
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings chart - Surperformance

Sector: Pharmaceuticals

1st Jan change Capi. Investor Rating ESG Refinitiv
ASTRAZENECA PLC Stock AstraZeneca PLC
+23.83% 247B -
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+62.66% 854B
C+
NOVO NORDISK A/S Stock Novo Nordisk A/S
+40.42% 636B
B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.37% 361B
C+
MERCK & CO., INC. Stock Merck & Co., Inc.
+17.16% 324B
B-
ABBVIE INC. Stock AbbVie Inc.
+9.87% 301B
C+
NOVARTIS AG Stock Novartis AG
+17.90% 228B
B-
AMGEN INC. Stock Amgen Inc.
+14.86% 177B
C+
PFIZER, INC. Stock Pfizer, Inc.
+0.45% 164B
C+
SANOFI Stock Sanofi
+5.17% 129B
B+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. AZN Stock
  4. AZN Stock
  5. Ratings AstraZeneca PLC